Feasibility of an innovative follow-up method alternating face-to-face consultations and teleconsultations for adult patients with cystic fibrosis (pwCF) treated with elexacaftor/tezacaftor/ivacaftor (ETI) for at least one year
Author:
Vidal Thomas,Durieu Isabelle,Perceval Marie,Reis-de-castro Rachel,Richard Mael,Roubertou Yoann,Reynaud Quitterie
Publication:
Respiratory Medicine and Research
© 2026 The Author(s). Published by Elsevier Masson SAS.